The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation
Abstract
The pathogenesis of Huntington's disease is still not completely understood. Several lines of evidence from toxic/non-transgenic animal models of Huntington's disease suggest that excitotoxic mechanisms may contribute to the pathological phenotype. Evidence from transgenic animal models of Huntington's disease, however, is sparse. To explore potential alterations in brain glutamate handling we studied transgenic mice expressing an N-terminal fragment of mutant huntingtin (R6/2). Intracerebral microdialysis in freely moving mice showed similar extracellular glutamate levels in R6/2 and littermate controls. However, partial inhibition of glutamate transport by L-trans-pyrrolidine-2,4-dicarboxylate (4 mM) disclosed an age-dependent increase in extracellular glutamate levels in R6/2 mice compared with controls, consistent with a reduction of functional glutamate transport capacity. Biochemical studies demonstrated an age-dependent downregulation of the glial glutamate transporter GLT-1 mRNA and protein, resulting in a progressive reduction of transporter function. Glutamate transporters other than GLT-1 were unchanged. In addition, increased extracellular glutamine levels and alterations to glutamine synthetase immunoreactivity suggested a perturbation of the glutamate-glutamine cycle. These findings demonstrate that the Huntington's disease mutation results in a progressively deranged glutamate handling in the brain, beginning before the onset of symptoms in mice. They also provide evidence for a contribution of excitotoxicity to the pathophysiology of Huntington's disease, and thus Huntington's disease may be added to the growing list of neurodegenerative disorders associated with compromised glutamate transport capacity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,417
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997) · Science · doi:10.1126/science.276.5319.1699 · Cited by 1,752
Astrocyte glutamate transport: Review of properties, regulation, and physiological functions
Anderson, C. M., & Swanson, R. A. (2000) · Glia · doi:10.1002/1098-1136(200010)32:1<1::aid-glia10>3.0.co;2-w · Cited by 1,216
Glutamine Synthetase: Glial Localization in Brain
Martinez-Hernandez, A., Bell, K. P., & Norenberg, M. D. (1977) · Science · doi:10.1126/science.14400 · Cited by 1,180
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,177
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 961
Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885
Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
Cartmell, J., & Schoepp, D. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750889.x · Cited by 883
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
Luthi-Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 720
Hertz, L. (1979) · Progress in Neurobiology · doi:10.1016/0301-0082(79)90018-2 · Cited by 628
Alternative excitotoxic hypotheses
Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574 · cited 2×
“Neuronal loss accompanied by ®brillary gliosis is most obvious in the striatum, where striatal projection neurones are preferentially lost (Albin et al., 1992).”
BackgroundTaurine in the central nervous system and the mammalian actions of taurine
Huxtable, R. J. (1989) · Progress in Neurobiology · doi:10.1016/0301-0082(89)90019-1 · Cited by 551
Cha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P., & Young, A. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6480 · Cited by 504
Neuronal Regulation of Glutamate Transporter Subtype Expression in Astrocytes
Swanson, R. A., Liu, J., Miller, J. W., Rothstein, J. D., Farrell, K., A. Stein, B., & Longuemare, M. C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00932.1997 · Cited by 500
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease
Beal, M., Ferrante, R., Swartz, K., & Kowall, N. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499
Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., & Davies, S. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110078997 · Cited by 430
Transcriptional dysregulation in Huntington’s disease
Cha, J.-H. J. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01609-x · Cited by 397
Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1
Lin, X., Antalffy, B., Kang, D., Orr, H. T., & Zoghbi, H. Y. (2000) · Nature Neuroscience · doi:10.1038/72101 · Cited by 374
Trotti, D., Rolfs, A., Danbolt, N. C., Brown, R. H., & Hediger, M. A. (1999) · Nature Neuroscience · doi:10.1038/8091 · Cited by 373
Albin, R. L., Reiner, A., Anderson, K. D., Dure, L. S., Handelin, B., Balfour, R., Whetsell, W. O., Penney, J. B., & Young, A. B. (1992) · Annals of Neurology · doi:10.1002/ana.410310412 · Cited by 368
Levine, M. S., Klapstein, G. J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M. E., Jokel, E. S., Carpenter, E. M., Zanjani, H., Hurst, R. S., et al. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4<515::aid-jnr5>3.0.co;2-f · Cited by 352
Compartmentation of Brain Glutamate Metabolism in Neurons and Glia
Daikhin, Y., & Yudkoff, M. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.4.1026s · Cited by 350
NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum
Landwehrmeyer, G., Standaert, D., Testa, C., Penney, J., & Young, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05297.1995 · Cited by 317
EXCITATORY AMINO ACID TRANSPORTERS: A Family in Flux
Seal, R. P., & Amara, S. G. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.431 · Cited by 312
Li, H., Li, S.-H., Johnston, H., Shelbourne, P. F., & Li, X.-J. (2000) · Nature Genetics · doi:10.1038/78054 · Cited by 303
Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy
Mathern, G. W., Mendoza, D., Lozada, A., Pretorius, J. K., Dehnes, Y., Danbolt, N. C., Nelson, N., Leite, J. P., Chimelli, L., Born, D. E., et al. (1999) · Neurology · doi:10.1212/wnl.52.3.453 · Cited by 291
Testa, C. M., Friberg, I. K., Weiss, S. W., & Standaert, D. G. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980105)390:1<5::aid-cne2>3.0.co;2-6 · Cited by 238
ARZBERGER, T., KRAMPFL, K., LEIMGRUBER, S., & WEINDL, A. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00013 · Cited by 232
Raghavendra Rao, V. L., Başkaya, M. K., Doğan, A., Rothstein, J. D., & Dempsey, R. J. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052020.x · Cited by 231
Zelenaia, O., Schlag, B. D., Gochenauer, G. E., Ganel, R., Song, W., Beesley, J. S., Grinspan, J. B., Rothstein, J. D., & Robinson, M. B. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26465-8 · Cited by 226
Jenkins, B. G., Klivenyi, P., Kustermann, E., Andreassen, O. A., Ferrante, R. J., Rosen, B. R., & Beal, M. F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742108.x · Cited by 175
Figiel, M., & Engele, J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03596.2000 · Cited by 170
Glutamine, Exercise and Immune Function: Links and Possible Mechanisms
Walsh, N. P., Blannin, A. K., Robson, P. J., & Gleeson, M. (1998) · Sports Medicine · doi:10.2165/00007256-199826030-00004 · Cited by 163
Massieu, L., Morales‐Villagrán, A., & Tapia, R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052262.x · Cited by 154
Butterworth, J., Yates, C. M., & Reynolds, G. P. (1985) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(85)90112-1 · Cited by 150
Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus
Torp, R., Lekieffre, D., Levy, L. M., Haug, F. Š., Danbolt, N. C., Meldrum, B. S., & Ottersen, O. P. (1995) · Experimental Brain Research · doi:10.1007/bf00241964 · Cited by 145
Robinson, M. B., Sinor, J. D., Dowd, L. A., & Kerwin, J. F. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05835.x · Cited by 145
Regional Deafferentiation Down‐Regulates Subtypes of Glutamate Transporter Proteins
Ginsberg, S. D., Martin, L. J., & Rothstein, J. D. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062800.x · Cited by 137
Down‐regulation of Glial Glutamate Transporters after Glutamatergic Denervation in the Rat Brain
Levy, L. M., Lehre, K. P., Walaas, S. I., Storm‐Mathisen, J., & Danbolt, N. C. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00626.x · Cited by 134
Bridges, R. J., Kavanaugh, M. P., & Chamberlin, A. R. (1999) · Current Pharmaceutical Design · doi:10.2174/138161280505230110101259 · Cited by 122
Segovia, G., Arco, A. D., & Mora, F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041476.x · Cited by 121
Volterra, A., Bezzi, P., Rizzini, B. L., Trotti, D., Ullensvang, K., Danbolt, N. C., & Racagni, G. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01345.x · Cited by 106
Brain Neurotransmitter Deficits in Mice Transgenic for the Huntington’s Disease Mutation
Reynolds, G. P., Dalton, C., Tillery, C. E., Mangiarini, L., Davies, S. W., & Bates, G. P. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721773.x · Cited by 95
Behrens, P. F., Langemann, H., Strohschein, R. J., Draeger, J., & Henning, J. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006426917654 · Cited by 94
Self-citationDecreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain
Reynolds, G. P., & Pearson, S. J. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90639-2 · Cited by 76
Glutamate Uptake Impairment and Neuronal Damage in Young and Aged Rats In Vivo
Massieu, L., & Tapia, R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031151.x · Cited by 73
Ginsberg, S. D., Rothstein, J. D., Price, D. L., & Martin, L. J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031208.x · Cited by 54
Modulation of Human Glutamate Transporter Activity by Phorbol Ester
Ganel, R., & Crosson, C. E. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70030993.x · Cited by 52
Lipid Metabolism and Membrane Composition Are Altered in the Brains of Type II Diabetic Mice
Makar, T. K., Hungund, B. L., Cook, G. A., Kashfi, K., & Cooper, A. J. L. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052159.x · Cited by 47
Rawls, S. M., & McGinty, J. F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041553.x · Cited by 41
Liévens, J.-C., Dutertre, M., Forni, C., Salin, P., & Goff, L. K. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00182-4 · Cited by 32
[43] Detection of polyglutamine aggregation in mouse models
Davies, S. W., Sathasivam, K., Hobbs, C., Doherty, P., Mangiarini, L., Scherzinger, E., Wanker, E. E., & Bates, G. P. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09045-x · Cited by 31
Zuiderwijk, M., Veenstra, E., Lopes, F. H. D. S., & Ghijsen, W. E. J. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00284-1 · Cited by 29
Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes
Kerner, J. A., Standaert, D. G., Penney, J. B., Young, A. B., & Landwehrmeyer, G. B. (1998) · Brain Research Protocols · doi:10.1016/s1385-299x(98)00017-8 · Cited by 29
Liévens, J.-C., Salin, P., Had‐Aissouni, L., Mahy, N., & Goff, L. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740909.x · Cited by 24
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1
Freye, E. C. K. (1997) · Journal of Neurosurgical Anesthesiology · doi:10.1097/00008506-199710000-00016 · Cited by 20
Glutamine, exercise and immune function: Links and possible mechanisms
Walsh, N. P., Blannin, A. K., Robson, P. J., et al. (1999) · Excerpta medica. Section 35, Occupational health and industrial medicine · Cited by 13
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Mechanisms of Disease: astrocytes in neurodegenerative disease
Maragakis, N. J., & Rothstein, J. D. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0355 · Cited by 812
Astrocytes: a central element in neurological diseases
Pekny, M., Pekna, M., Messing, A., Steinhäuser, C., Lee, J.-M., Parpura, V., Hol, E. M., Sofroniew, M. V., & Verkhratsky, A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1513-1 · Cited by 755
Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?
Lewerenz, J., & Maher, P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00469 · Cited by 718
Metadata
- Authors
- Behrens, P. F.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-08-01
- Volume
- 125
- Issue
- 8
- Pages
- 1908-1922
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2135573968
- Cited by
- 320
- References
- 63
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.